HK1257911A1 - Use of 7,8-dihydroxyflavone for treatment or prevention of cognitive decline associated with aging - Google Patents
Use of 7,8-dihydroxyflavone for treatment or prevention of cognitive decline associated with agingInfo
- Publication number
- HK1257911A1 HK1257911A1 HK19100273.7A HK19100273A HK1257911A1 HK 1257911 A1 HK1257911 A1 HK 1257911A1 HK 19100273 A HK19100273 A HK 19100273A HK 1257911 A1 HK1257911 A1 HK 1257911A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- dihydroxyflavone
- aging
- prevention
- treatment
- cognitive decline
- Prior art date
Links
- COCYGNDCWFKTMF-UHFFFAOYSA-N 7,8-dihydroxyflavone Chemical compound OC=1C(O)=CC=C(C(C=2)=O)C=1OC=2C1=CC=CC=C1 COCYGNDCWFKTMF-UHFFFAOYSA-N 0.000 title 2
- WWGFXSLWIRYIBP-UHFFFAOYSA-N 7,8-dihydroxy-4H-chromen-4-one Natural products O1C=CC(=O)C=2C1=C(O)C(O)=CC=2 WWGFXSLWIRYIBP-UHFFFAOYSA-N 0.000 title 1
- 230000032683 aging Effects 0.000 title 1
- 230000006999 cognitive decline Effects 0.000 title 1
- 208000010877 cognitive disease Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662424872P | 2016-11-21 | 2016-11-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1257911A1 true HK1257911A1 (en) | 2019-11-01 |
Family
ID=62801330
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK19100273.7A HK1257911A1 (en) | 2016-11-21 | 2019-01-08 | Use of 7,8-dihydroxyflavone for treatment or prevention of cognitive decline associated with aging |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN108272787B (en) |
| HK (1) | HK1257911A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114916665A (en) * | 2022-04-08 | 2022-08-19 | 苏州麦轮生物科技有限公司 | Nutritional supplement containing 7, 8-dihydroxyflavone and application thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014048370A1 (en) * | 2012-09-28 | 2014-04-03 | Jinhui Chen | Compositions and methods of treating and preventing neuronal damage from traumatic brain injury |
-
2017
- 2017-11-21 CN CN201711169037.7A patent/CN108272787B/en active Active
-
2019
- 2019-01-08 HK HK19100273.7A patent/HK1257911A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN108272787B (en) | 2021-05-28 |
| CN108272787A (en) | 2018-07-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1254665A1 (en) | Novel lactobacillus and composition for preventing, improving, or treating degenerative brain diseases or cognitive function disorders | |
| IL264049A (en) | Compounds, compositions, and methods for the treatment of disease | |
| HK1254358A1 (en) | Agents, uses and methods for the treatment of synucleinopathy | |
| IL271085A (en) | Bacteria for the treatment of disorders | |
| IL264156A (en) | Compounds, compositions, and methods for the treatment of disease | |
| IL266596A (en) | Agents, uses and methods for the treatment of synucleinopathy | |
| IL275482A (en) | Esketamine for the treatment of depression | |
| IL266047A (en) | Methods and compositions for the treatment of fabry disease | |
| HK1258276A1 (en) | Compounds and combinations for the treatment of hiv | |
| EP3328374A4 (en) | Glutamine antagonists for the treatment of cognitive deficits | |
| ZA201902091B (en) | Combination treatments comprising imidazopyrazinones for the treatment of psychiatric and/or cognitive disorders | |
| IL255185A0 (en) | 1-heteroaryl-indoline-4-carboxamides as modulators of gpr52 useful for the treatment or prevention of disorders related thereto | |
| SG11201700530PA (en) | Agent for improving brain function and agent for preventing or treating cognitive impairment | |
| GB201612165D0 (en) | Combinations for the treatment of type 2 diabetes | |
| HK1244211A1 (en) | Method for treating, preventing, or reducing the risk of skin infection | |
| PL3352745T3 (en) | Combination of dofetilide and mexiletine for the prevention and treatment of atrial fibrillation | |
| LT3493812T (en) | Combinations of imetelstat and venetoclax for the treatment of acute myeloid leukaemia | |
| EP3723742C0 (en) | Use of fluoroethylnormemantine for the prevention and treatment of anxiety | |
| HK1255695A1 (en) | Composition and methods for the treatment of blepharoptosis | |
| HK1257911A1 (en) | Use of 7,8-dihydroxyflavone for treatment or prevention of cognitive decline associated with aging | |
| GB201707207D0 (en) | Treatment of type 1 diabetes | |
| IL275027A (en) | Treatment of rsv with combination product | |
| GB201711677D0 (en) | Combination treatment | |
| GB201704949D0 (en) | Combination treatment | |
| GB201712881D0 (en) | Alternate between usage of the left or right brain |